Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1427, 2012-01, pp. : 26-26
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Infliximab/ustekinumab: Erythrodysaesthesia: case report
Reactions Weekly, Vol. 1, Iss. 1380, 2011-01 ,pp. :
Access to resources
Recommend
Adalimumab/infliximab: Psoriasiform lesions: 8 case reports
Reactions Weekly, Vol. 1, Iss. 1416, 2012-01 ,pp. :
Ustekinumab: Alopecia areata: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1420, 2012-01 ,pp. :
Infliximab: Hypersensitivity: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1012, 2004-01 ,pp. :
Infliximab: Psoriasis: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1127, 2006-01 ,pp. :